arrow
A

Andriy Derkach

Memorial Sloan Kettering Cancer Center
H指数:32
被引数:3,817

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model

动态风险分层在冒烟性多发性骨髓瘤中的应用:整合演变中的生物标志物与2/20/20模型

2026-09-240
OAAI
Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

基于病灶水平的PET/CT分析以识别多发性骨髓瘤中BCMA CAR T细胞治疗后进展的预测因子

2026-08-190
OAAI
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

粒细胞集落刺激因子对双特异性抗体启动期间细胞因子释放综合征的影响:在复发/难治性多发性骨髓瘤中的作用

2026-08-070
OAAI
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma

在多发性骨髓瘤患者中,强效CD4+ CAR T细胞扩增与非ICANS神经毒性的发生相关(cilta-cel治疗)

2026-07-290
PRE
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma

BCMA和GPRC5D嵌合抗原受体(CAR)T细胞在晚期多发性骨髓瘤中的联合给药

Blood
IF23.1
2026-07-080
PRE
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma

功能性高风险疾病与多发性骨髓瘤晚期CAR T细胞疗法后的不良预后相关

2026-04-120
OAAI
Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions

血浆细胞障碍患者中的饮食模式——针对干预的机会

2026-03-270
OAAI
Integrating genomic and non-genomic data to stratify the risk of contralateral breast cancer after radiotherapy

整合基因组和非基因组数据以分层放疗后对侧乳腺癌的风险

2026-02-260
PRE
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis

双特异性抗体疗法在RRMM中的早期死亡率:IMWG免疫疗法数据库真实世界分析

2026-02-260
OAAI
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

IMS-IMWG 2025年共识基因组分期可预测达雷木单抗为基础的四联方案对NDMM的疗效。

2026-02-190
OAAI
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

双特异性抗体治疗复发/难治性多发性骨髓瘤期间巨细胞病毒再激活

2025-11-010
OAAI
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL

阿糖胞苷治疗急性淋巴细胞白血病患者的静脉血栓栓塞风险预测模型的推导与外部验证

2025-11-010
OAAI
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

更正:达鲁珠单抗耐药性对复发难治性多发性骨髓瘤接受CAR T细胞治疗后临床结局的影响

2025-10-130
OA
Venetoclax in Combination With Pediatric-Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial

维奈克拉联合儿童启发的化疗方案治疗新诊断急性淋巴细胞白血病的成人患者:一项I期试验的结果

2025-09-270
PREAI